New Blood Cancer Therapy Gives a New Lease on Life To 73% of Patients
A novel treatment developed by researchers at The Tisch Cancer Institute of the Icahn School of Medicine at Mount Sinai could offer blood cancer patients a new lease on life. The therapy called talquetamab induces…